Optinose (NASDAQ:OPTN), a specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has approved XHANCE (fluticasone propionate) nasal spray for treating ...
Some results have been hidden because they may be inaccessible to you